ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1810

Health Care Utilization Preceding Diagnosis of Systemic Lupus Erythematosus in Youth

Joyce Chang1, Colleen Brensinger2, Liu Qing2 and Andrea Knight1,3,4, 1Division of Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 2Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, 3Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, 4PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: administrative databases, ICD-9, Pediatric rheumatology, systemic lupus erythematosus (SLE) and utilization review

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster II: Damage Accrual and Quality of Life

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Early diagnosis and treatment of youth with SLE are crucial to prevent organ damage and reduce mortality. Understanding health care utilization prior to diagnosis may inform interventions to minimize diagnostic delay. We determined the frequency and associated factors for health care visits among youth with SLE in the year prior to diagnosis.

Methods: We used national administrative claims data (Optum Labs Data Warehouse) for privately insured U.S. enrollees from May 2000 to December 2013 to identify an incident cohort of youth ages 10-24 years with SLE. Incident cases were defined by ≥ 3 outpatient or inpatient visit claims with an ICD-9 primary diagnosis code for SLE (710.0) > 30 days apart, with ≥ 1 year of preceding continuous enrollment without a code for SLE. The mean number of ambulatory (AMB), emergency (ED), and inpatient (IP) visits in the year prior to the first SLE diagnosis code were compared to visits per year for healthy controls matched 2:1 by age and sex. For each SLE visit type, we also calculated the mean number of visits in the 3 and 6 months prior to diagnosis, and determined the most frequent primary diagnosis codes in the year prior. We used multivariable negative binomial regression models to examine associations between demographic or disease-related factors and AMB, ED, and IP utilization in the year prior to SLE diagnosis.

Results: We included 724 SLE subjects and 1448 controls comprised of 88% females, with a mean age of 18.6 years (standard deviation, SD 3.7). Compared to controls, fewer youth with SLE were white or from the Midwest; 24% had subsequent diagnoses for nephritis. Youth with SLE had significantly higher mean visits of all types in the year pre-diagnosis compared to controls: 9.5 (SD 10.0) vs 3.0 (4.5) for AMB (p<0.001), 3.6 (6.0) vs 0.9 (2.0) for ED (p <0.001), and 1.4 (4.4) vs 0.2 (1.5) for IP (p<0.001) (Figure). The most common primary diagnosis codes for pre-diagnosis AMB, ED and IP visits were: Other acne [706.1], Primary thrombocytopenia unspecified [287.3], and Fever unspecified [780.6], respectively. Subsequent nephritis was associated with decreased AMB, but increased IP visits. Preceding psychiatric diagnosis was associated with increased AMB and ED visits (Table). Female sex, Asian and Black race were associated with decreased AMB visits.

Conclusion: Youth with SLE have higher rates of health care utilization in the year preceding diagnosis compared to healthy peers. Strategies to improve early identification of youth with SLE, especially those presenting with psychiatric or renal manifestations, may allow earlier treatment and improve outcomes.   


Disclosure: J. Chang, None; C. Brensinger, None; L. Qing, None; A. Knight, None.

To cite this abstract in AMA style:

Chang J, Brensinger C, Qing L, Knight A. Health Care Utilization Preceding Diagnosis of Systemic Lupus Erythematosus in Youth [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/health-care-utilization-preceding-diagnosis-of-systemic-lupus-erythematosus-in-youth/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/health-care-utilization-preceding-diagnosis-of-systemic-lupus-erythematosus-in-youth/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology